Welcome to BeiMedPlus
BeiGene's medical website with resources for healthcare professionals and disease information for patients and caregivers.
Catherine Thieblemont
Catherine Thieblemont, MD, PhD, is Head of the Hemato‑Oncology Department at Hôpital Saint‑Louis, part of the AP‑HP (Assistance Publique–Hôpitaux de Paris) in Paris, France.
Clinical focus and interest:
Chronic lymphoproliferative syndromes, including Hodgkin's and non-Hodgkin's lymphoma, and chronic and small lymphocytic leukemia (CLL/SLL).
Experience:
Dr. Thieblemont has made significant contributions to translational research and clinical development in aggressive and indolent B-cell malignancies, bringing extensive experience in overseeing clinical trials across all phases of the development lifecycle. She co-leads the Follicular and Other Indolent Lymphomas committee within the Lymphoma Study Association (LYSA), spearheading research into emerging and novel therapies.
Affiliations:
Dr. Thieblemont is the Head of the Hemato-Oncology Department at Hôpital Saint-Louis, Paris, France, and a Professor of Hematology at Paris Cité University.